Global Pulmonary Fibrosis Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pulmonary Fibrosis Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pulmonary Fibrosis Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pulmonary Fibrosis Drug by Country/Region, 2017, 2022 & 2028

2.2 Pulmonary Fibrosis Drug Segment by Type

2.2.1 Pirfenidone

2.2.2 Nintedanib

2.3 Pulmonary Fibrosis Drug Sales by Type

2.3.1 Global Pulmonary Fibrosis Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Pulmonary Fibrosis Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pulmonary Fibrosis Drug Sale Price by Type (2017-2022)

2.4 Pulmonary Fibrosis Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.5 Pulmonary Fibrosis Drug Sales by Application

2.5.1 Global Pulmonary Fibrosis Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Pulmonary Fibrosis Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pulmonary Fibrosis Drug Sale Price by Application (2017-2022)

3 Global Pulmonary Fibrosis Drug by Company

3.1 Global Pulmonary Fibrosis Drug Breakdown Data by Company

3.1.1 Global Pulmonary Fibrosis Drug Annual Sales by Company (2020-2022)

3.1.2 Global Pulmonary Fibrosis Drug Sales Market Share by Company (2020-2022)

3.2 Global Pulmonary Fibrosis Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Pulmonary Fibrosis Drug Revenue by Company (2020-2022)

3.2.2 Global Pulmonary Fibrosis Drug Revenue Market Share by Company (2020-2022)

3.3 Global Pulmonary Fibrosis Drug Sale Price by Company

3.4 Key Manufacturers Pulmonary Fibrosis Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pulmonary Fibrosis Drug Product Location Distribution

3.4.2 Players Pulmonary Fibrosis Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pulmonary Fibrosis Drug by Geographic Region

4.1 World Historic Pulmonary Fibrosis Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Pulmonary Fibrosis Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pulmonary Fibrosis Drug Annual Revenue by Geographic Region

4.2 World Historic Pulmonary Fibrosis Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Pulmonary Fibrosis Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pulmonary Fibrosis Drug Annual Revenue by Country/Region

4.3 Americas Pulmonary Fibrosis Drug Sales Growth

4.4 APAC Pulmonary Fibrosis Drug Sales Growth

4.5 Europe Pulmonary Fibrosis Drug Sales Growth

4.6 Middle East & Africa Pulmonary Fibrosis Drug Sales Growth

5 Americas

5.1 Americas Pulmonary Fibrosis Drug Sales by Country

5.1.1 Americas Pulmonary Fibrosis Drug Sales by Country (2017-2022)

5.1.2 Americas Pulmonary Fibrosis Drug Revenue by Country (2017-2022)

5.2 Americas Pulmonary Fibrosis Drug Sales by Type

5.3 Americas Pulmonary Fibrosis Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pulmonary Fibrosis Drug Sales by Region

6.1.1 APAC Pulmonary Fibrosis Drug Sales by Region (2017-2022)

6.1.2 APAC Pulmonary Fibrosis Drug Revenue by Region (2017-2022)

6.2 APAC Pulmonary Fibrosis Drug Sales by Type

6.3 APAC Pulmonary Fibrosis Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pulmonary Fibrosis Drug by Country

7.1.1 Europe Pulmonary Fibrosis Drug Sales by Country (2017-2022)

7.1.2 Europe Pulmonary Fibrosis Drug Revenue by Country (2017-2022)

7.2 Europe Pulmonary Fibrosis Drug Sales by Type

7.3 Europe Pulmonary Fibrosis Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pulmonary Fibrosis Drug by Country

8.1.1 Middle East & Africa Pulmonary Fibrosis Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pulmonary Fibrosis Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Pulmonary Fibrosis Drug Sales by Type

8.3 Middle East & Africa Pulmonary Fibrosis Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pulmonary Fibrosis Drug

10.3 Manufacturing Process Analysis of Pulmonary Fibrosis Drug

10.4 Industry Chain Structure of Pulmonary Fibrosis Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pulmonary Fibrosis Drug Distributors

11.3 Pulmonary Fibrosis Drug Customer

12 World Forecast Review for Pulmonary Fibrosis Drug by Geographic Region

12.1 Global Pulmonary Fibrosis Drug Market Size Forecast by Region

12.1.1 Global Pulmonary Fibrosis Drug Forecast by Region (2023-2028)

12.1.2 Global Pulmonary Fibrosis Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pulmonary Fibrosis Drug Forecast by Type

12.7 Global Pulmonary Fibrosis Drug Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim

13.1.1 Boehringer Ingelheim Company Information

13.1.2 Boehringer Ingelheim Pulmonary Fibrosis Drug Product Offered

13.1.3 Boehringer Ingelheim Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim Main Business Overview

13.1.5 Boehringer Ingelheim Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Pulmonary Fibrosis Drug Product Offered

13.2.3 Roche Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 FibroGen, Inc.

13.3.1 FibroGen, Inc. Company Information

13.3.2 FibroGen, Inc. Pulmonary Fibrosis Drug Product Offered

13.3.3 FibroGen, Inc. Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 FibroGen, Inc. Main Business Overview

13.3.5 FibroGen, Inc. Latest Developments

13.4 Merck & Co., Inc.

13.4.1 Merck & Co., Inc. Company Information

13.4.2 Merck & Co., Inc. Pulmonary Fibrosis Drug Product Offered

13.4.3 Merck & Co., Inc. Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck & Co., Inc. Main Business Overview

13.4.5 Merck & Co., Inc. Latest Developments

13.5 Bristol-Myers Squibb Company

13.5.1 Bristol-Myers Squibb Company Company Information

13.5.2 Bristol-Myers Squibb Company Pulmonary Fibrosis Drug Product Offered

13.5.3 Bristol-Myers Squibb Company Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bristol-Myers Squibb Company Main Business Overview

13.5.5 Bristol-Myers Squibb Company Latest Developments

13.6 MediciNova, Inc.

13.6.1 MediciNova, Inc. Company Information

13.6.2 MediciNova, Inc. Pulmonary Fibrosis Drug Product Offered

13.6.3 MediciNova, Inc. Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 MediciNova, Inc. Main Business Overview

13.6.5 MediciNova, Inc. Latest Developments

13.7 Genentech, Inc.

13.7.1 Genentech, Inc. Company Information

13.7.2 Genentech, Inc. Pulmonary Fibrosis Drug Product Offered

13.7.3 Genentech, Inc. Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Genentech, Inc. Main Business Overview

13.7.5 Genentech, Inc. Latest Developments

13.8 Cipla Inc.

13.8.1 Cipla Inc. Company Information

13.8.2 Cipla Inc. Pulmonary Fibrosis Drug Product Offered

13.8.3 Cipla Inc. Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Cipla Inc. Main Business Overview

13.8.5 Cipla Inc. Latest Developments

13.9 Biogen

13.9.1 Biogen Company Information

13.9.2 Biogen Pulmonary Fibrosis Drug Product Offered

13.9.3 Biogen Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biogen Main Business Overview

13.9.5 Biogen Latest Developments

13.10 Galapagos NV

13.10.1 Galapagos NV Company Information

13.10.2 Galapagos NV Pulmonary Fibrosis Drug Product Offered

13.10.3 Galapagos NV Pulmonary Fibrosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Galapagos NV Main Business Overview

13.10.5 Galapagos NV Latest Developments

14 Research Findings and Conclusion

Table 1. Pulmonary Fibrosis Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pulmonary Fibrosis Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Pirfenidone

Table 4. Major Players of Nintedanib

Table 5. Global Pulmonary Fibrosis Drug Sales by Type (2017-2022) & (K Units)

Table 6. Global Pulmonary Fibrosis Drug Sales Market Share by Type (2017-2022)

Table 7. Global Pulmonary Fibrosis Drug Revenue by Type (2017-2022) & ($ million)

Table 8. Global Pulmonary Fibrosis Drug Revenue Market Share by Type (2017-2022)

Table 9. Global Pulmonary Fibrosis Drug Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Pulmonary Fibrosis Drug Sales by Application (2017-2022) & (K Units)

Table 11. Global Pulmonary Fibrosis Drug Sales Market Share by Application (2017-2022)

Table 12. Global Pulmonary Fibrosis Drug Revenue by Application (2017-2022)

Table 13. Global Pulmonary Fibrosis Drug Revenue Market Share by Application (2017-2022)

Table 14. Global Pulmonary Fibrosis Drug Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Pulmonary Fibrosis Drug Sales by Company (2020-2022) & (K Units)

Table 16. Global Pulmonary Fibrosis Drug Sales Market Share by Company (2020-2022)

Table 17. Global Pulmonary Fibrosis Drug Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Pulmonary Fibrosis Drug Revenue Market Share by Company (2020-2022)

Table 19. Global Pulmonary Fibrosis Drug Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Pulmonary Fibrosis Drug Producing Area Distribution and Sales Area

Table 21. Players Pulmonary Fibrosis Drug Products Offered

Table 22. Pulmonary Fibrosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Pulmonary Fibrosis Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Pulmonary Fibrosis Drug Sales Market Share Geographic Region (2017-2022)

Table 27. Global Pulmonary Fibrosis Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Pulmonary Fibrosis Drug Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Pulmonary Fibrosis Drug Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Pulmonary Fibrosis Drug Sales Market Share by Country/Region (2017-2022)

Table 31. Global Pulmonary Fibrosis Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Pulmonary Fibrosis Drug Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Pulmonary Fibrosis Drug Sales by Country (2017-2022) & (K Units)

Table 34. Americas Pulmonary Fibrosis Drug Sales Market Share by Country (2017-2022)

Table 35. Americas Pulmonary Fibrosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Pulmonary Fibrosis Drug Revenue Market Share by Country (2017-2022)

Table 37. Americas Pulmonary Fibrosis Drug Sales by Type (2017-2022) & (K Units)

Table 38. Americas Pulmonary Fibrosis Drug Sales Market Share by Type (2017-2022)

Table 39. Americas Pulmonary Fibrosis Drug Sales by Application (2017-2022) & (K Units)

Table 40. Americas Pulmonary Fibrosis Drug Sales Market Share by Application (2017-2022)

Table 41. APAC Pulmonary Fibrosis Drug Sales by Region (2017-2022) & (K Units)

Table 42. APAC Pulmonary Fibrosis Drug Sales Market Share by Region (2017-2022)

Table 43. APAC Pulmonary Fibrosis Drug Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Pulmonary Fibrosis Drug Revenue Market Share by Region (2017-2022)

Table 45. APAC Pulmonary Fibrosis Drug Sales by Type (2017-2022) & (K Units)

Table 46. APAC Pulmonary Fibrosis Drug Sales Market Share by Type (2017-2022)

Table 47. APAC Pulmonary Fibrosis Drug Sales by Application (2017-2022) & (K Units)

Table 48. APAC Pulmonary Fibrosis Drug Sales Market Share by Application (2017-2022)

Table 49. Europe Pulmonary Fibrosis Drug Sales by Country (2017-2022) & (K Units)

Table 50. Europe Pulmonary Fibrosis Drug Sales Market Share by Country (2017-2022)

Table 51. Europe Pulmonary Fibrosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Pulmonary Fibrosis Drug Revenue Market Share by Country (2017-2022)

Table 53. Europe Pulmonary Fibrosis Drug Sales by Type (2017-2022) & (K Units)

Table 54. Europe Pulmonary Fibrosis Drug Sales Market Share by Type (2017-2022)

Table 55. Europe Pulmonary Fibrosis Drug Sales by Application (2017-2022) & (K Units)

Table 56. Europe Pulmonary Fibrosis Drug Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Pulmonary Fibrosis Drug Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Pulmonary Fibrosis Drug Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Pulmonary Fibrosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Pulmonary Fibrosis Drug Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Pulmonary Fibrosis Drug Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Pulmonary Fibrosis Drug Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Pulmonary Fibrosis Drug Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Pulmonary Fibrosis Drug Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Pulmonary Fibrosis Drug

Table 66. Key Market Challenges & Risks of Pulmonary Fibrosis Drug

Table 67. Key Industry Trends of Pulmonary Fibrosis Drug

Table 68. Pulmonary Fibrosis Drug Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Pulmonary Fibrosis Drug Distributors List

Table 71. Pulmonary Fibrosis Drug Customer List

Table 72. Global Pulmonary Fibrosis Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Pulmonary Fibrosis Drug Sales Market Forecast by Region

Table 74. Global Pulmonary Fibrosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Pulmonary Fibrosis Drug Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Pulmonary Fibrosis Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Pulmonary Fibrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Pulmonary Fibrosis Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Pulmonary Fibrosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Pulmonary Fibrosis Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Pulmonary Fibrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Pulmonary Fibrosis Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Pulmonary Fibrosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Pulmonary Fibrosis Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Pulmonary Fibrosis Drug Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Pulmonary Fibrosis Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Pulmonary Fibrosis Drug Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Pulmonary Fibrosis Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Pulmonary Fibrosis Drug Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Pulmonary Fibrosis Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Pulmonary Fibrosis Drug Revenue Market Share Forecast by Application (2023-2028)

Table 92. Boehringer Ingelheim Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 93. Boehringer Ingelheim Pulmonary Fibrosis Drug Product Offered

Table 94. Boehringer Ingelheim Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Boehringer Ingelheim Main Business

Table 96. Boehringer Ingelheim Latest Developments

Table 97. Roche Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. Roche Pulmonary Fibrosis Drug Product Offered

Table 99. Roche Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Roche Main Business

Table 101. Roche Latest Developments

Table 102. FibroGen, Inc. Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. FibroGen, Inc. Pulmonary Fibrosis Drug Product Offered

Table 104. FibroGen, Inc. Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. FibroGen, Inc. Main Business

Table 106. FibroGen, Inc. Latest Developments

Table 107. Merck & Co., Inc. Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Merck & Co., Inc. Pulmonary Fibrosis Drug Product Offered

Table 109. Merck & Co., Inc. Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Merck & Co., Inc. Main Business

Table 111. Merck & Co., Inc. Latest Developments

Table 112. Bristol-Myers Squibb Company Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 113. Bristol-Myers Squibb Company Pulmonary Fibrosis Drug Product Offered

Table 114. Bristol-Myers Squibb Company Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Bristol-Myers Squibb Company Main Business

Table 116. Bristol-Myers Squibb Company Latest Developments

Table 117. MediciNova, Inc. Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 118. MediciNova, Inc. Pulmonary Fibrosis Drug Product Offered

Table 119. MediciNova, Inc. Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. MediciNova, Inc. Main Business

Table 121. MediciNova, Inc. Latest Developments

Table 122. Genentech, Inc. Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 123. Genentech, Inc. Pulmonary Fibrosis Drug Product Offered

Table 124. Genentech, Inc. Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Genentech, Inc. Main Business

Table 126. Genentech, Inc. Latest Developments

Table 127. Cipla Inc. Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 128. Cipla Inc. Pulmonary Fibrosis Drug Product Offered

Table 129. Cipla Inc. Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Cipla Inc. Main Business

Table 131. Cipla Inc. Latest Developments

Table 132. Biogen Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 133. Biogen Pulmonary Fibrosis Drug Product Offered

Table 134. Biogen Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Biogen Main Business

Table 136. Biogen Latest Developments

Table 137. Galapagos NV Basic Information, Pulmonary Fibrosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 138. Galapagos NV Pulmonary Fibrosis Drug Product Offered

Table 139. Galapagos NV Pulmonary Fibrosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Galapagos NV Main Business

Table 141. Galapagos NV Latest Developments

List of Figures

Figure 1. Picture of Pulmonary Fibrosis Drug

Figure 2. Pulmonary Fibrosis Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pulmonary Fibrosis Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Pulmonary Fibrosis Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pulmonary Fibrosis Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Pirfenidone

Figure 10. Product Picture of Nintedanib

Figure 11. Global Pulmonary Fibrosis Drug Sales Market Share by Type in 2021

Figure 12. Global Pulmonary Fibrosis Drug Revenue Market Share by Type (2017-2022)

Figure 13. Pulmonary Fibrosis Drug Consumed in Hospital

Figure 14. Global Pulmonary Fibrosis Drug Market: Hospital (2017-2022) & (K Units)

Figure 15. Pulmonary Fibrosis Drug Consumed in Clinic

Figure 16. Global Pulmonary Fibrosis Drug Market: Clinic (2017-2022) & (K Units)

Figure 17. Global Pulmonary Fibrosis Drug Sales Market Share by Application (2017-2022)

Figure 18. Global Pulmonary Fibrosis Drug Revenue Market Share by Application in 2021

Figure 19. Pulmonary Fibrosis Drug Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Pulmonary Fibrosis Drug Revenue Market Share by Company in 2021

Figure 21. Global Pulmonary Fibrosis Drug Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Pulmonary Fibrosis Drug Revenue Market Share by Geographic Region in 2021

Figure 23. Global Pulmonary Fibrosis Drug Sales Market Share by Region (2017-2022)

Figure 24. Global Pulmonary Fibrosis Drug Revenue Market Share by Country/Region in 2021

Figure 25. Americas Pulmonary Fibrosis Drug Sales 2017-2022 (K Units)

Figure 26. Americas Pulmonary Fibrosis Drug Revenue 2017-2022 ($ Millions)

Figure 27. APAC Pulmonary Fibrosis Drug Sales 2017-2022 (K Units)

Figure 28. APAC Pulmonary Fibrosis Drug Revenue 2017-2022 ($ Millions)

Figure 29. Europe Pulmonary Fibrosis Drug Sales 2017-2022 (K Units)

Figure 30. Europe Pulmonary Fibrosis Drug Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Pulmonary Fibrosis Drug Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Pulmonary Fibrosis Drug Revenue 2017-2022 ($ Millions)

Figure 33. Americas Pulmonary Fibrosis Drug Sales Market Share by Country in 2021

Figure 34. Americas Pulmonary Fibrosis Drug Revenue Market Share by Country in 2021

Figure 35. United States Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Pulmonary Fibrosis Drug Sales Market Share by Region in 2021

Figure 40. APAC Pulmonary Fibrosis Drug Revenue Market Share by Regions in 2021

Figure 41. China Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Pulmonary Fibrosis Drug Sales Market Share by Country in 2021

Figure 48. Europe Pulmonary Fibrosis Drug Revenue Market Share by Country in 2021

Figure 49. Germany Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Pulmonary Fibrosis Drug Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Pulmonary Fibrosis Drug Revenue Market Share by Country in 2021

Figure 56. Egypt Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Pulmonary Fibrosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Pulmonary Fibrosis Drug in 2021

Figure 62. Manufacturing Process Analysis of Pulmonary Fibrosis Drug

Figure 63. Industry Chain Structure of Pulmonary Fibrosis Drug

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles